Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Ocugen Inc. (OCGN)

2.22   0.04 (1.83%) 01-17 17:33
Open: 2.26 Pre. Close: 2.18
High: 2.3782 Low: 2.12
Volume: 17,853,797 Market Cap: 360M
Ocugen, Inc. engages in the development and commercialization of therapies for eye diseases. The company is headquartered in Malvern, Pennsylvania and currently employs 49 full-time employees. The firm offers a diversified ophthalmology portfolio that includes gene therapies, biologics, and small molecules and targets a range of retinal and ocular surface diseases. The firm is leveraging its modifier gene therapy platform to address genetically diverse inherited retinal disorders and dry age-related macular degeneration (AMD), based on nuclear hormone receptor genes NR2E3 (OCU400) and RORA (OCU410), respectively. The firm is also developing biologic therapies for wet-AMD, diabetic macular edema (DME) and diabetic retinopathy (OCU200), as well as for retinitis pigmentosa (OCU100).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.382 - 2.399 2.399 - 2.412
Low: 2.091 - 2.108 2.108 - 2.12
Close: 2.198 - 2.224 2.224 - 2.244

Technical analysis

as of: 2021-01-15 4:43:48 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 4.09     One year: 4.77
Support: Support1: 1.51    Support2: 0.28
Resistance: Resistance1: 3.50    Resistance2: 4.09
Pivot: 2.37
Moving Average: MA(5): 2.32     MA(20): 1.99
MA(100): 0.65     MA(250): 0.49
MACD: MACD(12,26): 0.46     Signal(9): 0.52
Stochastic oscillator: %K(14,3): 43.37     %D(3): 53.91
RSI: RSI(14): 57.00
52-week: High: 3.50  Low: 0.17  Change(%): 221.7
Average Vol(K): 3-Month: 4914205  10-Days: 4904364

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
OCGN has closed above bottom band by 39.7%. Bollinger Bands are 148.6% wider than normal. The large width of the bands suggest high volatility as compared to OCGN's normal range. The bands have been in this wide range for 16 bars. This is a sign that the current trend might continue.

Headline News

Fri, 15 Jan 2021
Premarket Mover: Ocugen Inc (OCGN) Up 4.59% - InvestorsObserver

Thu, 14 Jan 2021
Do Traders View Ocugen Inc (OCGN) Stock's Current Trend Positively? - InvestorsObserver

Wed, 13 Jan 2021
Ocugen climbs after management indicated positive events - Seeking Alpha

Wed, 13 Jan 2021
Should You Buy Ocugen Inc (OCGN) Stock Wednesday? - InvestorsObserver

Tue, 12 Jan 2021
Ocugen Inc. Announces the Cancellation of Stockholder Meeting Previously Adjourned to 11:00 a.m. Eastern Time on January 13, 2021 - GlobeNewswire

Fri, 08 Jan 2021
Ocugen Inc. Regains Compliance with Nasdaq Bid Price Rule - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 162
Shares Float (M) 156
% Held by Insiders 3.26
% Held by Institutions 13.12
Shares Short (K) 4,980
Shares Short P. Month (K) 5,140

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin -32042.68
Return on Assets (ttm) -38.7
Return on Equity (ttm) -850.6
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.084
Qtrly Earnings Growth
Operating Cash Flow (M) -19
Levered Free Cash Flow (M) -34

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales 8439.85
Price to Cash Flow -18.76

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.